Nicolle M - Search Results

1

Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes.

Burke G, Cossins J, Maxwell S, Owens G, Vincent A, Robb S, Nicolle M, Hilton-Jones D, Newsom-Davis J, Palace J, Beeson D. Burke G, et al. Among authors: nicolle m. Neurology. 2003 Sep 23;61(6):826-8. doi: 10.1212/01.wnl.0000085865.55513.ae. Neurology. 2003. PMID: 14504330

2

Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.

Nicolle MW, Nag B, Sharma SD, Willcox N, Vincent A, Ferguson DJ, Newsom-Davis J. Nicolle MW, et al. J Clin Invest. 1994 Apr;93(4):1361-9. doi: 10.1172/JCI117112. J Clin Invest. 1994. PMID: 7512979 Free PMC article.

3

Involvement of cation channels in autoimmune disease.

Vincent A, Barrett-Jolley R, Shillito P, Hart I, Beeson D, MacLennan C, Nicolle M, Lang B, Roberts M, Willison H, et al. Vincent A, et al. Among authors: nicolle m. Biochem Soc Trans. 1994 May;22(2):488-91. doi: 10.1042/bst0220488. Biochem Soc Trans. 1994. PMID: 7525378 Review. No abstract available.

4

Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor.

Matsuo H, Batocchi AP, Hawke S, Nicolle M, Jacobson L, Vincent A, Newsom-Davis J, Willcox N. Matsuo H, et al. Among authors: nicolle m. J Immunol. 1995 Oct 1;155(7):3683-92. J Immunol. 1995. PMID: 7561069

5

Differences in processing of an autoantigen by DR4:Dw4.2 and DR4:Dw14.2 antigen-presenting cells.

Nicolle MW, Hawke S, Willcox N, Vincent A. Nicolle MW, et al. Eur J Immunol. 1995 Jul;25(7):2119-22. doi: 10.1002/eji.1830250749. Eur J Immunol. 1995. PMID: 7621887

6

Presentation of endogenous acetylcholine receptor epitope by an MHC class II-transfected human muscle cell line to a specific CD4+ T cell clone from a myasthenia gravis patient.

Baggi F, Nicolle M, Vincent A, Matsuo H, Willcox N, Newsom-Davis J. Baggi F, et al. Among authors: nicolle m. J Neuroimmunol. 1993 Jul;46(1-2):57-65. doi: 10.1016/0165-5728(93)90233-o. J Neuroimmunol. 1993. PMID: 7689595

7

An in vitro model for disease-specific immunotherapy in myasthenia gravis using soluble MHC class II bound to AChR-derived peptide.

Nicolle MW, Vincent A, Sharma S, Nag B, Willcox N, Newsom-Davis J. Nicolle MW, et al. Ann N Y Acad Sci. 1993 Jun 21;681:577-80. doi: 10.1111/j.1749-6632.1993.tb22946.x. Ann N Y Acad Sci. 1993. PMID: 8357203 No abstract available.

8

Heterogeneity and immunotherapy of specific T-cells in myasthenia gravis.

Bond A, Corlett L, Nagvekar N, Jacobson L, Pantic N, Beeson D, Nicolle M, Vincent A, Newsom-Davis J, Spack E, Willcox N. Bond A, et al. Among authors: nicolle m. Biochem Soc Trans. 1997 May;25(2):665-70. doi: 10.1042/bst0250665. Biochem Soc Trans. 1997. PMID: 9191178 Review. No abstract available.

9

Distinct phenotypes of congenital acetylcholine receptor deficiency.

Burke G, Cossins J, Maxwell S, Robb S, Nicolle M, Vincent A, Newsom-Davis J, Palace J, Beeson D. Burke G, et al. Among authors: nicolle m. Neuromuscul Disord. 2004 Jun;14(6):356-64. doi: 10.1016/j.nmd.2004.03.005. Neuromuscul Disord. 2004. PMID: 15145336 Clinical Trial.

10

Sleep apnea in patients with myasthenia gravis.

Nicolle MW, Rask S, Koopman WJ, George CF, Adams J, Wiebe S. Nicolle MW, et al. Neurology. 2006 Jul 11;67(1):140-2. doi: 10.1212/01.wnl.0000223515.15691.26. Neurology. 2006. PMID: 16832094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters